| in millions of euros, unless otherwise stated, | |||
for the year ended December 31 | 2025 | 2024 | |
Revenues | Note 5/6 | ||
Cost of revenues | Note 5 | ( | ( |
Gross profit | Note 5 | ||
Sales costs | Note 9 | ( | ( |
General and administrative costs | Note 10 | ( | ( |
Total operating expenses | Note 5 | ( | ( |
Other gains and (losses) | Note 11 | ( | |
Operating profit | Note 5 | ||
Financing income | |||
Financing costs | ( | ( | |
Other finance income and (costs) | ( | ( | |
Total financing results | Note 14 | ( | ( |
Share of profit of equity-accounted associates, net of tax | Note 20 | ||
Profit before tax | |||
Income tax expense | Note 15 | ( | ( |
Profit for the year | |||
| Attributable to: | |||
Owners of the company | |||
Non-controlling interests | Note 16 | ||
Profit for the year | |||
| Earnings per share (EPS) (€) | |||
Basic EPS | Note 7 | ||
Diluted EPS | Note 7 |
| in millions of euros, | |||
for the year ended December 31 | 2025 | 2024 | |
| Comprehensive income | |||
Profit for the year | |||
| Other comprehensive income | |||
Items that are or may be reclassified subsequently to the consolidated statement ofprofitorloss: | |||
Exchange differences on translation of foreign operations | ( | ||
| Exchange differences on translation of equity-accounted | |||
associates | Note 20 | ( | |
Recycling of foreign exchange differences on loss of control | Note 8 | ( | |
| Gains/(losses) on hedges of net investments in foreign | |||
operations | ( | ||
Gains/(losses) on cash flow hedges | ( | ( | |
Net change in fair value of cash flow hedges reclassified to the consolidated statementofprofit or loss | Note 14 | ||
| Items that will not be reclassified to the consolidated statement | |||
| of profit or loss: | |||
Remeasurement gains/(losses) on defined benefit plans | Note 30 | ( | |
Other comprehensive income/(loss) for the year, before tax | ( | ||
| Income tax on items that are or may be reclassified | |||
subsequently to the consolidated statement ofprofit or loss | |||
Income tax on items that will not be reclassified to the consolidated statement of profit orloss | ( | ||
Income tax on other comprehensive income | Note 22 | ||
Other comprehensive income/(loss) for the year | ( | ||
Total comprehensive income for the year | |||
| Attributable to: | |||
Owners of the company | |||
Non-controlling interests | |||
Total comprehensive income for the year |
in millions of euros, for the year ended December 31 | 2025 | 2024 | |
| Cash flows from operating activities | |||
Profit for the year | |||
| Adjustments for: | |||
Income tax expense | Note 15 | ||
Share of profit of equity-accounted associates, net of tax | Note 20 | ( | ( |
Financing results | Note 14 | ||
Amortization, impairment, and depreciation | Note 13 | ||
Book (profit)/loss on disposal of operations and non- current assets | ( | ( | |
Fair value changes of contingent considerations | Note 11 | ||
Additions to and releases from provisions | Note 31 | ||
Appropriation of provisions | Note 31 | ( | ( |
Changes in employee benefit provisions | ( | ||
Share-based payments | Note 12 | ||
Other adjustments | |||
Adjustments excluding autonomous movements in working capital | |||
Inventories | |||
Contract assets | Note 24 | ( | |
Trade and other receivables | ( | ( | |
Deferred income | Note 24 | ||
Other contract liabilities | Note 24 | ( | |
Trade and other payables | |||
Autonomous movements in working capital | |||
Total adjustments | |||
Net cash flows from operations | |||
| Interest paid (including the interest portion of lease | |||
payments) | ( | ( | |
Interest received | |||
Paid income tax | Note 22 | ( | ( |
Net cash from operating activities |
in millions of euros, for the year ended December 31 | 2025 | 2024* | |
| Cash flows from investing activities | |||
Capital expenditure | Note 17/18 | ( | ( |
Proceeds from disposal of other intangible assets and property, plant, and equipment | |||
Acquisition spending, net of cash acquired | Note 8 | ( | ( |
Receipts from divestments, net of cash disposed | Note 8 | ||
Dividends received | |||
Net cash used in investing activities | ( | ( | |
| Cash flows from financing activities | |||
Repayment of loans | Note 28 | ( | ( |
Proceeds from new loans | Note 28 | ||
Repayment of principal portion of lease liabilities | Note 19 | ( | ( |
Collateral received/(paid) | ( | ( | |
Repurchased shares | Note 32 | ( | ( |
Cash used for settlement of net investment hedges | ( | ||
Dividends paid | ( | ( | |
Net cash used in financing activities | ( | ( | |
Net cash flows before effect of exchange differences | ( | ||
| Exchange differences on cash and cash equivalents and bank | |||
overdrafts | ( | ||
Net change in cash and cash equivalents and bank overdrafts | ( | ( | |
Cash and cash equivalents less bank overdrafts at January 1 | |||
Cash and cash equivalents less bank overdrafts at December 31 | Note 26 | ||
Add: Bank overdrafts at December 31 | Note 26 | ||
Cash and cash equivalents in the consolidated statement of financial position at December 31 | Note 26 |
in millions of euros, at December 31 | 2025 | 2024 | |
| Non-current assets | |||
Goodwill | Note 17 | ||
Intangible assets other than goodwill | Note 17 | ||
Property, plant, and equipment | Note 18 | ||
Right-of-use assets | Note 19 | ||
Investments in equity-accounted associates | Note 20 | ||
Financial assets | Note 21 | ||
Non-current other receivables | Note 25 | ||
Non-current contract assets | Note 24 | ||
Deferred tax assets | Note 22 | ||
Total non-current assets | |||
| Current assets | |||
Inventories | Note 23 | ||
Contract assets | Note 24 | ||
Trade receivables | Note 24 | ||
Other receivables | Note 25 | ||
Current income tax assets | Note 22 | ||
Cash and cash equivalents | Note 26/28 | ||
Total current assets | |||
Total assets |
in millions of euros, at December 31 | 2025 | 2024 | |
| Equity | |||
Issued share capital | Note 32 | ||
Share premium reserve | |||
Legal reserves | |||
Treasury shares | ( | ( | |
Retained earnings | |||
Equity attributable to the owners of the company | Note 48 | ||
Non-controlling interests | Note 16 | ||
Total equity | |||
| Non-current liabilities | |||
Bonds | |||
Private placements | |||
Lease liabilities | |||
Other long-term debt | |||
Total long-term debt | Note 28 | ||
Deferred tax liabilities | Note 22 | ||
Employee benefits | Note 30 | ||
Provisions | Note 31 | ||
Non-current deferred income | Note 24 | ||
Total non-current liabilities | |||
| Current liabilities | |||
Deferred income | Note 24 | ||
Other contract liabilities | Note 24 | ||
Trade and other payables | Note 27 | ||
Current income tax liabilities | Note 22 | ||
Short-term provisions | Note 31 | ||
Borrowings and bank overdrafts | Note 28 | ||
Short-term bonds | Note 28 | ||
Short-term lease liabilities | Note 28 | ||
Total current liabilities | |||
Total liabilities | |||
Total equity and liabilities |
| Issued | Share | Legal reserves | Other reserves | Non- | ||||||
| share | premium | Legal reserve | Hedge | Translation | Treasury | Retained | Shareholders’ | controlling | ||
| in millions of euros | capital | reserve | participations | reserve | reserve | shares | earnings | equity | interests | Total equity |
Balance at January 1, 2024 | ( | ( | ||||||||
Profit for the year | ||||||||||
Other comprehensive income/(loss) for the year | ( | ( | ||||||||
Total comprehensive income for theyear | ( | |||||||||
Transactions with owners of the company, recognized directly in equity: | ||||||||||
Share-based payments | ||||||||||
Cancelation of shares | ( | ( | ||||||||
Release LTIP shares | ( | |||||||||
Final cash dividend 2023 | ( | ( | ( | ( | ||||||
Interim cash dividend 2024 | ( | ( | ( | |||||||
Repurchased shares | ( | ( | ( | |||||||
Other movements | ( | |||||||||
Balance at December 31, 2024 | ( | ( | ||||||||
Balance at January 1, 2025 | ( | ( | ||||||||
Profit for the year | ||||||||||
Other comprehensive income/(loss) for the year | ( | ( | ( | |||||||
Total comprehensive income for theyear | ( | |||||||||
Transactions with owners of the company, recognized directly in equity: | ||||||||||
Share-based payments | ||||||||||
Cancelation of shares | ( | ( | ||||||||
Release LTIP shares | ( | |||||||||
Final cash dividend 2024 | ( | ( | ( | |||||||
Interim cash dividend 2025 | ( | ( | ( | |||||||
Repurchased shares | ( | ( | ( | |||||||
Other movements | ( | |||||||||
Balance at December 31, 2025 | ( | ( |
| Main currency exchange rates | ||
rates to the euro | 2025 | 2024 |
U.S. dollar (average) | 1.13 | 1.08 |
U.S. dollar (at December 31) | 1.18 | 1.04 |
| Note 5 – Segment reporting | ||||||||||||||||
in millions of euros, unless otherwise stated | Health | Tax & Accounting | Compliance | Financial & Corporate | Legal & Regulatory | Corporate | Performance & ESG | segments | Total reportable | Corporate** | Total | |||||
reporting by segment | 2025 | 2024 | 2025 | 2024 | 2025 | 2024* | 2025 | 2024 | 2025 | 2024* | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
Revenues from contracts with third parties | 1,596 | 1,584 | 1,660 | 1,561 | 1,239 | 1,228 | 1,005 | 946 | 625 | 597 | 6,125 | 5,916 | - | - | 6,125 | 5,916 |
Cost of revenues | (459) | (479) | (430) | (421) | (304) | (298) | (260) | (257) | (172) | (171) | (1,625) | (1,626) | - | - | (1,625) | (1,626) |
Gross profit | 1,137 | 1,105 | 1,230 | 1,140 | 935 | 930 | 745 | 689 | 453 | 426 | 4,500 | 4,290 | 0 | 0 | 4,500 | 4,290 |
Sales costs | (240) | (237) | (228) | (227) | (156) | (170) | (169) | (162) | (182) | (173) | (975) | (969) | - | - | (975) | (969) |
General and administrative costs | (416) | (424) | (443) | (413) | (377) | (363) | (428) | (378) | (254) | (223) | (1,918) | (1,801) | (77) | (69) | (1,995) | (1,870) |
Total operating expenses | (656) | (661) | (671) | (640) | (533) | (533) | (597) | (540) | (436) | (396) | (2,893) | (2,770) | (77) | (69) | (2,970) | (2,839) |
Other gains and (losses) | (1) | (4) | (2) | (3) | 223 | 1 | (14) | (4) | (1) | - | 205 | (10) | - | - | 205 | (10) |
Operating profit | 480 | 440 | 557 | 497 | 625 | 398 | 134 | 145 | 16 | 30 | 1,812 | 1,510 | (77) | (69) | 1,735 | 1,441 |
Amortization of acquired identifiable intangible assets | 31 | 34 | 25 | 19 | 35 | 36 | 35 | 27 | 31 | 31 | 157 | 147 | - | - | 157 | 147 |
| Impairment of goodwill | - | 2 | - | - | - | - | - | - | - | - | 0 | 2 | - | - | 0 | 2 |
Non-benchmark items in operating profit | 1 | 4 | 2 | 3 | (223) | (1) | 14 | 4 | 1 | - | (205) | 10 | - | - | (205) | 10 |
Adjusted operating profit | 512 | 480 | 584 | 519 | 437 | 433 | 183 | 176 | 48 | 61 | 1,764 | 1,669 | (77) | (69) | 1,687 | 1,600 |
Amortization of other intangible assets and depreciation of PPE and right-of-use assets | (44) | (47) | (80) | (80) | (60) | (67) | (66) | (64) | (56) | (49) | (306) | (307) | 0 | 0 | (306) | (307) |
Impairment of other intangible assets, PPE, and right-of-use assets | (2) | (13) | (2) | (4) | (8) | (4) | (1) | (2) | (1) | - | (14) | (23) | 0 | 0 | (14) | (23) |
Goodwill and acquired identifiable intangible assets at December 31 | 1,133 | 1,300 | 1,531 | 1,656 | 1,380 | 1,287 | 1,258 | 755 | 617 | 650 | 5,919 | 5,648 | - | - | 5,919 | 5,648 |
Net capital expenditure | 41 | 43 | 71 | 68 | 63 | 77 | 54 | 53 | 74 | 72 | 303 | 313 | 0 | 0 | 303 | 313 |
Number of FTEs at December 31 | 3,571 | 3,401 | 6,790 | 7,159 | 3,126 | 3,917 | 4,388 | 4,147 | 2,551 | 2,428 | 20,426 | 21,052 | 141 | 148 | 20,567 | 21,200 |
| Total non-current assets per geographic region | 2025 | 2024 | ||
in millions of euros, unless otherwise stated | % | % | ||
599 | 9 | 703 | 11 | |
Europe (excluding the Netherlands) | 2,060 | 30 | 1,642 | 24 |
U.S. and Canada | 4,165 | 60 | 4,352 | 64 |
Asia Pacific | 79 | 1 | 71 | 1 |
Rest of World | 17 | 0 | 17 | 0 |
Total | 6,920 | 100 | 6,785 | 100 |
| Note 6 – Revenues | ||
2025 | 2024 | |
Revenues from contracts with third parties | 6,125 | 5,916 |
| Revenues by recognition pattern and contract length | ||||||||||||
Health | Tax & Accounting | Compliance | Financial & Corporate | Legal & Regulatory | Corporate | Performance & ESG | Total | |||||
reporting by segment | 2025 | 2024 | 2025 | 2024 | 2025 | 2024* | 2025 | 2024 | 2025 | 2024* | 2025 | 2024 |
| Revenue per recognition pattern | ||||||||||||
At a point in time recognition | 257 | 259 | 186 | 197 | 383 | 379 | 248 | 252 | 52 | 70 | 1,126 | 1,157 |
Over time recognition | 1,339 | 1,325 | 1,474 | 1,364 | 856 | 849 | 757 | 694 | 573 | 527 | 4,999 | 4,759 |
Revenues from contracts with third parties | 1,596 | 1,584 | 1,660 | 1,561 | 1,239 | 1,228 | 1,005 | 946 | 625 | 597 | 6,125 | 5,916 |
| Revenue per contract length | ||||||||||||
Contracts one year or less | 956 | 1,010 | 1,524 | 1,404 | 946 | 920 | 725 | 685 | 293 | 306 | 4,444 | 4,325 |
Multi-year contracts | 640 | 574 | 136 | 157 | 293 | 308 | 280 | 261 | 332 | 291 | 1,681 | 1,591 |
Revenues from contracts with third parties | 1,596 | 1,584 | 1,660 | 1,561 | 1,239 | 1,228 | 1,005 | 946 | 625 | 597 | 6,125 | 5,916 |
| Revenues by media format | ||||||||||||
Health | Tax & Accounting | Compliance | Financial & Corporate | Legal & Regulatory | Corporate | Performance & ESG | Total | |||||
reporting by segment | 2025 | 2024 | 2025 | 2024 | 2025 | 2024* | 2025 | 2024 | 2025 | 2024* | 2025 | 2024 |
Digital | 1,459 | 1,427 | 1,590 | 1,495 | 699 | 701 | 877 | 815 | 625 | 597 | 5,250 | 5,035 |
Services | 3 | 4 | 36 | 34 | 535 | 522 | 10 | 9 | 0 | 0 | 584 | 569 |
Print | 134 | 153 | 34 | 32 | 5 | 5 | 118 | 122 | - | - | 291 | 312 |
Revenues from contracts with third parties | 1,596 | 1,584 | 1,660 | 1,561 | 1,239 | 1,228 | 1,005 | 946 | 625 | 597 | 6,125 | 5,916 |
| Recurring/non-recurring revenues | ||||||||||||
Health | Tax & Accounting | Compliance | Financial & Corporate | Legal & Regulatory | Corporate | Performance & ESG | Total | |||||
reporting by segment | 2025 | 2024 | 2025 | 2024 | 2025 | 2024* | 2025 | 2024 | 2025 | 2024* | 2025 | 2024 |
Recurring revenues | 1,476 | 1,449 | 1,526 | 1,431 | 841 | 824 | 804 | 746 | 463 | 418 | 5,110 | 4,868 |
Non-recurring revenues | 120 | 135 | 134 | 130 | 398 | 404 | 201 | 200 | 162 | 179 | 1,015 | 1,048 |
Revenues from contracts with third parties | 1,596 | 1,584 | 1,660 | 1,561 | 1,239 | 1,228 | 1,005 | 946 | 625 | 597 | 6,125 | 5,916 |
| Revenues by type | ||||
Digital and service subscription | 4,700 | 2025 | 4,458 | 2024 |
Print subscription | 118 | 125 | ||
Other recurring | 292 | 285 | ||
Total recurring revenues | 5,110 | 4,868 | ||
Print books | 115 | 120 | ||
| Transactional - Financial & Corporate | ||||
Compliance* | 343 | 336 | ||
Transactional - Legal & Regulatory* | 104 | 100 | ||
Other non-recurring** | 453 | 492 | ||
Total non-recurring revenues | 1,015 | 1,048 | ||
Revenues from contracts with third parties | 6,125 | 5,916 |
| Revenues per geographic region | 2025 | 2024 | ||
in millions of euros, unless otherwise stated | % | % | ||
The Netherlands | 261 | 4 | 248 | 4 |
Europe (excluding the Netherlands) | 1,533 | 25 | 1,415 | 24 |
U.S. and Canada | 3,860 | 63 | 3,791 | 64 |
Asia Pacific | 352 | 6 | 351 | 6 |
Rest of World | 119 | 2 | 111 | 2 |
Revenues from contracts with third parties | 6,125 | 100 | 5,916 | 100 |
| Profit for the year | ||
2025 | 2024 | |
Profit for the year attributable to the owners of the company (A) | 1,308 | 1,079 |
| Weighted-average number of ordinary shares for the year | |||
In millions of shares, unless otherwise stated | 2025 | 2024 | |
Outstanding ordinary shares at January 1 | Note 32 | 238.5 | 248.5 |
Effect of cancelation of shares | (1.7) | (2.9) | |
Effect of repurchased shares | (5.8) | (8.1) | |
Weighted-average number of ordinary shares (B) | 231.0 | 237.5 | |
Basic EPS (A/B) (€) | 5.66 | 4.54 |
| Diluted weighted-average number of ordinary shares for the year | ||
In millions of shares, unless otherwise stated | 2025 | 2024 |
Weighted-average number of ordinary shares (B) | 231.0 | 237.5 |
Effect of long-term incentive plan (LTIP) | 0.8 | 0.9 |
Diluted weighted-average number of ordinary shares (C) | 231.8 | 238.4 |
Diluted EPS (A/C) (€) | 5.64 | 4.52 |
| Acquisitions | ||||||
2025 | 2024 | |||||
| Other | Recognized | Recognized | ||||
RASi | Brightflag | acquisitions | values | values | ||
Consideration payable in cash | 386 | 436 | 52 | 874 | 357 | |
| Deferred and contingent considerations at fair value: | ||||||
| Non-current | - | - | 49 | 49 | - | |
| Current | - | - | - | 0 | - | |
Total consideration | 386 | 436 | 101 | 923 | 357 | |
Intangible assets other than goodwill | Note 17 | - | - | - | 0 | 0 |
Fair value adjustments of acquired identifiable intangible assets | Note 17 | 179 | 179 | 69 | 427 | 185 |
| Note | ||||||
| Other non-current assets | 18/19 | 3 | 2 | 0 | 5 | 4 |
Current assets | 16 | 11 | 2 | 29 | 33 | |
Current liabilities | (23) | (14) | (8) | (45) | (12) | |
Non-current liabilities | Note 28 | (3) | 0 | (1) | (4) | (4) |
| Employee benefits | - | - | 0 | 0 | (1) | |
Deferred tax assets/(liabilities) | (23) | (22) | (18) | (63) | (45) | |
Fair value of net identifiable assets | 149 | 156 | 44 | 349 | 160 | |
Goodwill on acquisitions | Note 17 | 237 | 280 | 57 | 574 | 197 |
| Cash effect of acquisitions: | ||||||
Consideration payable in cash | 874 | 357 | ||||
Cash acquired | (5) | (25) | ||||
Deferred and contingent considerations paid | Note 29 | 2 | 3 | |||
Acquisition spending, net of cash acquired | 871 | 335 |
| Contribution of 2025 acquisitions | ||||
| Adjusted | FTEs at | |||
| operating | Profit for the | December 31, | ||
| Revenues | profit | year 2025 | ||
Totals excluding the impact of 2025 acquisitions | 6,063 | 1,670 | 1,308 | 20,111 |
Contribution of 2025 acquisitions | 62 | 17 | 0 | 456 |
Totals for the year 2025 | 6,125 | 1,687 | 1,308 | 20,567 |
Pro forma contribution of 2025 acquisitions for the period January 1, 2025, up to acquisition date | 27 | 4 | (14) | |
Pro forma totals for the year 2025 | 6,152 | 1,691 | 1,294 | 20,567 |
| Divestments | |||
| Divestment of operations: | 2025 | 2024 | |
Consideration receivable in cash | 415 | 1 | |
Deferred divestment consideration receivable | 4 | 0 | |
Consideration receivable | 419 | 1 | |
Intangible assets | 198 | 3 | |
Other non-current assets | 7 | 0 | |
Current assets | 35 | 3 | |
Current liabilities | (69) | (6) | |
Deferred tax assets/(liabilities) | 1 | (1) | |
Non-current liabilities | (7) | - | |
Net identifiable assets/(liabilities) | 165 | (1) | |
Reclassification of foreign exchange differences on loss of control to profit or loss, previously recognized in other comprehensive income | (4) | 1 | |
Book profit/(loss) on divestments of operations | 250 | 3 | |
Divestment-related costs | (16) | (5) | |
Restructuring of stranded costs following divestments | Note 31 | (3) | (1) |
Divestment-related results included in other gains and (losses) | Note 11 | 231 | (3) |
| Cash effect of divestments: | |||
Consideration receivable in cash | 415 | 1 | |
Cash included in divested operations | (16) | 0 | |
Receipts from divestments, net of cash disposed | 399 | 1 |
2025 | 2024 | ||
Marketing and promotion costs | 248 | 258 | |
Sales-related costs – sales commissions directly expensed | 165 | 171 | |
| Sales-related costs – amortization of capitalized sales | |||
commissions | Note 24 | 29 | 29 |
Other sales-related costs | 414 | 407 | |
Customer support costs | 94 | 86 | |
| Additions to and releases from loss allowances on trade | |||
receivables and unbilled revenues | Note 24 | 25 | 18 |
Total | 975 | 969 |
2025 | 2024 | ||
Research, development, and editorial costs | 724 | 688 | |
General and administrative operating expenses | 1,114 | 1,033 | |
| Amortization and impairment of acquired identifiable | |||
intangible assets and goodwill | Note 13 | 157 | 149 |
Total | 1,995 | 1,870 |
2025 | 2024 | ||
Acquisition-related costs | Note 8 | (25) | (7) |
Additions to acquisition integration provisions | Note 31 | (1) | 0 |
Fair value changes of contingent considerations | Note 29 | 0 | 0 |
Divestment-related results | Note 8 | 231 | (3) |
Total | 205 | (10) |
in millions of euros, unless otherwise stated | 2025 | 2024 | |
Salaries and wages and other benefits | 2,025 | 1,963 | |
Social security charges | 173 | 167 | |
Medical cost benefits | 115 | 102 | |
Expenses related to defined contribution plans | 109 | 105 | |
Expenses related to defined benefit plans | Note 30 | 17 | (10) |
Equity-settled share-based payments | Note 33 | 26 | 31 |
Total | 2,465 | 2,358 | |
2025 | 2024 | ||
Amortization of acquired identifiable intangible assets | Note 17 | 157 | 147 |
Impairment of goodwill | Note 17 | - | 2 |
Amortization of other intangible assets | Note 17 | 227 | 223 |
Impairment of other intangible assets | Note 17 | 14 | 22 |
Depreciation of property, plant, and equipment | Note 18 | 24 | 24 |
Impairment of property, plant, and equipment | Note 18 | 0 | 1 |
Depreciation of right-of-use assets | Note 19 | 55 | 60 |
Total | 477 | 479 |
2025 | 2024 | ||||
Current income tax expense | 360 | 323 | |||
Adjustments previous years | (4) | (12) | |||
| Deferred tax expense: | |||||
Changes in tax rates | (2) | 0 | |||
Origination and reversal of temporary differences | (13) | (12) | |||
Movements in deferred tax assets and liabilities | Note 22 | (15) | (12) | ||
Total | Note 22 | 341 | 299 |
% | 2025 | % | 2024 | |
Profit before tax | 1,649 | 1,378 | ||
Income tax expense at the Dutch statutory income tax rate | 25.8 | 426 | 25.8 | 356 |
| Tax effect of: | ||||
Rate differential | (2.3) | (38) | (3.1) | (42) |
Tax incentives, exempt income, and divestments | (5.0) | (81) | (2.0) | (27) |
Recognized and unrecognized tax losses | 0.6 | 10 | 0.5 | 6 |
Adjustments previous years | (0.2) | (4) | (0.8) | (12) |
Changes in income tax rates | (0.1) | (2) | 0.0 | 0 |
Other taxes | 0.9 | 15 | 1.1 | 15 |
Pillar Two Global Minimum Tax | 0.2 | 3 | 0.3 | 5 |
Non-deductible costs and other items | 0.8 | 12 | (0.1) | (2) |
Total | 20.7 | 341 | 21.7 | 299 |
ownership in % | 2025 | 2024 |
Akadémiai Kiadó Kft. (Budapest, Hungary) | 74 | 74 |
| Acquired | ||||||||||
| identifiable | Other | |||||||||
| Customer | intangible | intangible | ||||||||
| Position at January 1 | Goodwill | relationships | Technology | Brand names | Content | assets | assets | 2025 | 2024 | |
Cost value | 4,710 | 1,243 | 617 | 487 | 159 | 2,506 | 2,341 | 9,557 | 8,660 | |
| Accumulated amortization and impairment | - | (693) | (325) | (429) | (121) | (1,568) | (1,544) | (3,112) | (2,740) | |
Book value at January 1 | 4,710 | 550 | 292 | 58 | 38 | 938 | 797 | 6,445 | 5,920 | |
| Movements | ||||||||||
| Investments | - | - | - | - | - | 0 | 283 | 283 | 293 | |
Acquired through business combinations | Note 8 | 574 | 294 | 113 | 20 | 0 | 427 | 0 | 1,001 | 382 |
Divestment of operations | Note 8 | (93) | (10) | (2) | - | - | (12) | (93) | (198) | (3) |
| Disposal of assets | - | - | - | - | - | 0 | 0 | 0 | 0 | |
Net expenditures | 481 | 284 | 111 | 20 | 0 | 415 | 190 | 1,086 | 672 | |
Amortization | Note 13 | - | (83) | (57) | (9) | (8) | (157) | (227) | (384) | (370) |
Impairment | Note 13 | - | - | - | - | - | 0 | (14) | (14) | (24) |
Reclassifications | 1 | - | (1) | - | - | (1) | - | 0 | (1) | |
Foreign exchange differences | (405) | (53) | (3) | (3) | (4) | (63) | (53) | (521) | 248 | |
Total movements | 77 | 148 | 50 | 8 | (12) | 194 | (104) | 167 | 525 | |
| Position at December 31 | ||||||||||
Cost value | 4,787 | 1,228 | 668 | 450 | 140 | 2,486 | 2,081 | 9,354 | 9,557 | |
| Accumulated amortization and impairment | - | (530) | (326) | (384) | (114) | (1,354) | (1,388) | (2,742) | (3,112) | |
Book value at December 31 | 4,787 | 698 | 342 | 66 | 26 | 1,132 | 693 | 6,612 | 6,445 |
| Acquired | Acquired | |||||
| identifiable | identifiable | |||||
| intangible | intangible | |||||
| Goodwill | assets | 2025 | Goodwill | assets | 2024* | |
Health | 1,042 | 91 | 1,133 | 1,177 | 123 | 1,300 |
Tax & Accounting | 1,308 | 223 | 1,531 | 1,401 | 255 | 1,656 |
| Financial & Corporate | ||||||
Compliance | 1,095 | 285 | 1,380 | 1,101 | 186 | 1,287 |
Legal & Regulatory | 925 | 333 | 1,258 | 614 | 141 | 755 |
Corporate Performance & ESG | 417 | 200 | 617 | 417 | 233 | 650 |
Total | 4,787 | 1,132 | 5,919 | 4,710 | 938 | 5,648 |
| Land and | |||||
| Position at January 1 | buildings | Other PPE | 2025 | 2024 | |
Cost value | 90 | 179 | 269 | 268 | |
Accumulated depreciation and impairment | (60) | (130) | (190) | (189) | |
Book value at January 1 | 30 | 49 | 79 | 79 | |
| Movements | |||||
Investments | 1 | 21 | 22 | 21 | |
Acquired through business combinations | Note 8 | 0 | 1 | 1 | 0 |
| Divestment of operations | - | (1) | (1) | - | |
Disposal of assets | (2) | - | (2) | (1) | |
Net expenditures | (1) | 21 | 20 | 20 | |
Depreciation | Note 13 | (5) | (19) | (24) | (24) |
Impairment | Note 13 | - | 0 | 0 | (1) |
Foreign exchange differences | (2) | (5) | (7) | 5 | |
Total movements | (8) | (3) | (11) | 0 | |
| Position at December 31 | |||||
Cost value | 78 | 159 | 237 | 269 | |
Accumulated depreciation and impairment | (56) | (113) | (169) | (190) | |
Book value at December 31 | 22 | 46 | 68 | 79 |
| Movement schedule of right-of-use assets | |||||
| Other | |||||
| Position at January 1 | Real estate | leases | 2025 | 2024 | |
Cost value | 556 | 53 | 609 | 623 | |
Accumulated depreciation and impairment | (367) | (28) | (395) | (382) | |
Book value at January 1 | 189 | 25 | 214 | 241 | |
| Movements | |||||
Additions from new leases | 29 | 15 | 44 | 23 | |
Acquired through business combinations | Note 8 | 4 | - | 4 | 4 |
Additions from contract modifications and reassessment of options | 16 | - | 16 | 14 | |
Other movements from contract modifications and reassessment of options | (6) | - | (6) | (16) | |
Divestment of operations | (4) | (2) | (6) | - | |
Net additions | 39 | 13 | 52 | 25 | |
Depreciation | Note 13 | (42) | (13) | (55) | (60) |
Foreign exchange differences | (15) | - | (15) | 8 | |
Total movements | (18) | 0 | (18) | (27) | |
| Position at December 31 | |||||
Cost value | 517 | 42 | 559 | 609 | |
Accumulated depreciation and impairment | (346) | (17) | (363) | (395) | |
Book value at December 31 | 171 | 25 | 196 | 214 |
| Contractual maturities of lease liabilities | ||
2025 | 2024 | |
Within one year | 58 | 65 |
Between one and two years | 50 | 53 |
Between two and three years | 41 | 44 |
Between three and four years | 30 | 34 |
Between four and five years | 20 | 24 |
Between five and ten years | 37 | 48 |
| Ten years and more | - | - |
Effect of discounting | (19) | (26) |
Total lease liabilities at December 31 | 217 | 242 |
| Cash outflow for leases | 2025 | 2024 |
Interest portion of lease payments | 7 | 8 |
Repayment of principal portion of lease liabilities | 58 | 62 |
Total | 65 | 70 |
ownership in % | 2025 | 2024 |
Haoyisheng (Beijing, China) | 22 | 22 |
| Movement schedule of equity-accounted associates | ||
2025 | 2024 | |
Position at January 1 | 13 | 11 |
Share of profit of equity-accounted associates, net of tax | 2 | 2 |
Foreign exchange differences | (1) | 0 |
Position at December 31 | 14 | 13 |
| Share in financial information: | ||||
| Total equity-accounted | ||||
associates | Group’s share | |||
2025 | 2024 | 2025 | 2024 | |
Total assets | 40 | 43 | 8 | 9 |
Total liabilities | 21 | 26 | 5 | 5 |
Total equity | 19 | 17 | 3 | 4 |
Revenues | 24 | 26 | 5 | 6 |
Net profit for the year | 5 | 2 | 2 | 2 |
2025 | 2024 | |
Financial assets at fair value through profit or loss | 0 | 0 |
Finance lease receivables | 0 | 1 |
Other non-current financial assets | 3 | 4 |
Total | 3 | 5 |
| Deferred tax assets and liabilities | ||||
temporary differences arising from: | Assets | Liabilities | 2025 | 2024 |
Intangible assets | 18 | (429) | (411) | (424) |
| Property, plant, and equipment, right-of-use | ||||
assets, and lease liabilities | 55 | (43) | 12 | 19 |
Employee benefits | 33 | - | 33 | 42 |
Tax value of loss carry-forwards recognized | 5 | - | 5 | 17 |
Other items | 85 | (21) | 64 | 78 |
Total before set-off of tax | 196 | (493) | (297) | (268) |
Set-off of tax | (165) | 165 | 0 | 0 |
Position at December 31 | 31 | (328) | (297) | (268) |
| Movements in temporary differences 2025 | ||||||
| Recognized | ||||||
| Balance at | in profit or | Recognized | Foreign | Balance at | ||
| January 1, | Acquisitions/ | loss | in equity | exchange | December | |
| 2025 | divestments | (Note 15) | and OCI | differences | 31, 2025 | |
Intangible assets | (424) | (62) | 42 | - | 33 | (411) |
| PPE, right-of-use assets, and lease | ||||||
liabilities | 19 | - | (5) | - | (2) | 12 |
Employee benefits | 42 | - | (4) | (1) | (4) | 33 |
| Tax value of loss carry-forwards | ||||||
recognized | 17 | - | (10) | - | (2) | 5 |
Other items | 78 | (2) | (8) | 1 | (5) | 64 |
Total | (268) | (64) | 15 | 0 | 20 | (297) |
| Movements in temporary differences 2024 | ||||||
| Recognized | ||||||
| Balance at | in profit or | Recognized | Foreign | Balance at | ||
| January 1, | Acquisitions/ | loss | in equity | exchange | December | |
| 2024 | divestments | (Note 15) | and OCI | differences | 31, 2024 | |
Intangible assets | (392) | (44) | 31 | - | (19) | (424) |
| PPE, right-of-use assets, and lease | ||||||
liabilities | 21 | - | (2) | - | 0 | 19 |
Employee benefits | 37 | - | 1 | 1 | 3 | 42 |
| Tax value of loss carry-forwards | ||||||
recognized | 23 | - | (8) | - | 2 | 17 |
Other items | 81 | (1) | (10) | 4 | 4 | 78 |
Total | (230) | (45) | 12 | 5 | (10) | (268) |
| Movements in overall tax position | |||
| Position at January 1 | 2025 | 2024 | |
Current income tax assets | 82 | 86 | |
Current income tax liabilities | (117) | (128) | |
Deferred tax assets | 56 | 51 | |
Deferred tax liabilities | (324) | (281) | |
Overall tax position | (303) | (272) | |
| Movements | |||
Total income tax expense | Note 15 | (341) | (299) |
Deferred tax from acquisitions and divestments | (64) | (45) | |
Current income tax from acquisitions and divestments | (2) | 0 | |
Deferred tax on items recognized directly in OCI | 0 | 5 | |
Paid income tax | 358 | 318 | |
Foreign exchange differences | 28 | (10) | |
Total movements | (21) | (31) | |
| Position at December 31 | |||
Current income tax assets | 103 | 82 | |
Current income tax liabilities | (130) | (117) | |
Deferred tax assets | 31 | 56 | |
Deferred tax liabilities | (328) | (324) | |
Overall tax position | (324) | (303) |
| Deferred tax on items recognized immediately in other comprehensive income and equity | ||||||
2025 | 2024 | |||||
| Amount | Amount | Amount | Amount | |||
| before | net of | before | net of | |||
| Exchange differences on translation of foreign | tax | Tax | tax | tax | Tax | tax |
| operations, recycling of foreign exchange | ||||||
| differences on loss of control, and net | ||||||
investment hedges | (415) | (1) | (416) | 214 | 0 | 214 |
Gains/(losses) on cash flow hedges | (7) | 2 | (5) | (7) | 4 | (3) |
| Remeasurement gains/(losses) on defined | ||||||
benefit plans | 4 | (1) | 3 | (5) | 1 | (4) |
Recognized in other comprehensive income | (418) | 0 | (418) | 202 | 5 | 207 |
Share-based payments | 26 | - | 26 | 31 | - | 31 |
Recognized in equity | 26 | 0 | 26 | 31 | 0 | 31 |
2025 | 2024 | |
Work in progress | 13 | 18 |
Finished products and trade goods | 49 | 61 |
Total | 62 | 79 |
2025 | 2024 | |
Trade receivables | 1,075 | 1,129 |
Non-current contract assets | 19 | 18 |
Current contract assets | 147 | 148 |
Non-current deferred income | 140 | 110 |
Current deferred income | 1,911 | 2,054 |
Other current contract liabilities | 88 | 76 |
| Loss allowances | |||
2025 | 2024 | ||
Position at January 1 | 89 | 85 | |
Additions to loss allowances | Note 9 | 51 | 35 |
Releases from loss allowances | Note 9 | (26) | (17) |
Usage of loss allowances | (24) | (23) | |
Acquired through business combinations | 2 | 0 | |
Divestment of operations | (9) | - | |
Foreign exchange differences | (7) | 9 | |
Position at December 31 | 76 | 89 |
| Contract assets | ||||||
| Cost to | Cost to | |||||
| Unbilled | obtain a | fulfill a | ||||
| current and non-current | revenues | contract | contract | 2025 | 2024 | |
Position at January 1 | 80 | 43 | 43 | 166 | 178 | |
Recognized as revenues in the year | 503 | - | - | 503 | 443 | |
Newly recognized cost to fulfill a contract | - | - | 400 | 400 | 405 | |
Transferred to trade receivables | (491) | - | (392) | (883) | (866) | |
Newly recognized cost to obtain a contract | - | 34 | - | 34 | 31 | |
| Amortization of capitalized sales | ||||||
commissions | Note 9 | - | (29) | - | (29) | (29) |
| Autonomous movements in contract | ||||||
assets | 12 | 5 | 8 | 25 | (16) | |
| Acquired through business | ||||||
combinations | Note 8 | - | - | - | 0 | 0 |
Divestment of operations | (4) | (2) | - | (6) | 0 | |
Foreign exchange differences | (8) | (3) | (8) | (19) | 4 | |
Position at December 31 | 80 | 43 | 43 | 166 | 166 |
| Deferred income | ||
current and non-current | 2025 | 2024 |
Position at January 1 | 2,164 | 2,001 |
New and existing contracts with customers | 4,758 | 4,562 |
Recognized as revenues from opening balance | (2,054) | (1,899) |
Recognized as revenues in the year on new and existing contracts | (2,617) | (2,544) |
Change in netting against trade receivables | 19 | (46) |
Autonomous movements in deferred income | 106 | 73 |
Acquired through business combinations | 31 | 4 |
Divestment of operations | (47) | (6) |
Foreign exchange differences | (203) | 92 |
Position at December 31 | 2,051 | 2,164 |
| Other contract liabilities | ||
2025 | 2024 | |
Position at January 1 | 76 | 86 |
Recognized as revenues in the year on new and existing contracts | 158 | 130 |
Change in netting against trade receivables | (140) | (139) |
Autonomous movements in deferred income | 18 | (9) |
Acquired through business combinations | 2 | - |
Foreign exchange differences | (8) | (1) |
Position at December 31 | 88 | 76 |
2025 | 2024 | ||
Prepaid royalties | 8 | 11 | |
Non-current other receivables | 8 | 11 | |
Prepaid royalties | 87 | 70 | |
Other prepayments | 177 | 154 | |
VAT, sales tax, and other taxation | 19 | 22 | |
Miscellaneous receivables | 14 | 16 | |
Interest receivable | 1 | 1 | |
Collateral | 12 | 2 | |
Deferred divestment receivables | 4 | 0 | |
Derivative financial instruments | Note 29 | 0 | - |
Current other receivables | 314 | 265 |
2025 | 2024 | ||
Deposits | 533 | 417 | |
Cash and bank balances | 399 | 537 | |
| Total cash and cash equivalents in the consolidated statement | |||
of financial position | 932 | 954 | |
Minus: Bank overdrafts used for cash management purposes | Note 28 | (41) | (9) |
Total cash and cash equivalents minus bank overdrafts | 891 | 945 |
2025 | 2024 | ||
Trade payables | 131 | 159 | |
Salaries, holiday allowances, and other benefits | 358 | 326 | |
VAT, sales tax, social security premiums, and other taxation | 97 | 99 | |
Pension-related payables | 31 | 32 | |
Royalty payables | 106 | 104 | |
Other accruals and payables | 322 | 311 | |
Interest payable | 68 | 51 | |
Share buyback payable | 4 | 0 | |
Deferred and contingent acquisition payables | Note 29 | 1 | 2 |
Derivative financial instruments | Note 29 | 0 | 3 |
Total | 1,118 | 1,087 |
| Effective | Nominal | Repayment | Repayment | ||||||
| in millions of euros, unless | Nominal | interest | interest | commitments | commitments | ||||
| otherwise stated | value | rate in % | rate in % | 1-5 years | >5 years | 2025 | 2024 | ||
Bonds 2008-2028 (100.00*) | € 36 | 6.812 | 6.748 | 36 | - | 36 | 36 | ||
Bonds 2017-2027 (99.659*) | € 500 | 1.575 | 1.500 | 500 | - | 500 | 499 | ||
Bonds 2020-2030 (99.292*) | € 500 | 0.862 | 0.750 | 498 | - | 498 | 497 | ||
Bonds 2021-2028 (99.958*) | € 500 | 0.307 | 0.250 | 499 | - | 499 | 499 | ||
Bonds 2022-2026 (99.922*) | € 500 | 3.096 | 3.000 | - | - | 0 | 499 | ||
Bonds 2023-2031 (99.417*) | € 700 | 3.877 | 3.750 | - | 696 | 696 | 695 | ||
Bonds 2024-2029 (99.964*) | € 600 | 3.316 | 3.250 | 599 | - | 599 | 599 | ||
Bonds 2025-2032 (99.278*) | € 500 | 3.538 | 3.375 | - | 495 | 495 | - | ||
Bonds 2025-2030 (99.975*) | € 500 | 3.054 | 3.000 | 499 | - | 499 | - | ||
Bonds, measured at amortized cost | 2,631 | 1,191 | 3,822 | 3,324 | |||||
| Private placements | |||||||||
2008-20 | 38, | measured at | |||||||
amortized cost | 0 | 108 | 108 | 122 | |||||
| Deferred and contingent | |||||||||
acquisition payables, measured at fair value | 49 | - | 49 | 0 | |||||
Other debt, measured at amortized cost | 16 | - | 16 | 21 | |||||
| Derivative financial | |||||||||
instruments, measured at fair value** | - | 38 | 38 | 17 | |||||
Other long-term debt | 65 | 38 | 103 | 38 | |||||
| Total long-term debt | |||||||||
(excluding lease liabilities) | 2,696 | 1,337 | 4,033 | 3,484 | |||||
Lease liabilities*** | 160 | 179 | |||||||
Total long-term debt | 4,193 | 3,663 |
2025 | 2024 | ||
Total long-term debt | 4,193 | 3,663 | |
| Borrowings and bank overdrafts: | |||
Euro Commercial Paper program | 180 | 350 | |
Bank overdrafts, measured at amortized cost | Note 26 | 41 | 9 |
Total borrowings and bank overdrafts | 221 | 359 | |
Bonds 2022-2026 | 500 | - | |
Short-term lease liabilities | 57 | 63 | |
Deferred and contingent acquisition payables measured at fair value | 1 | 2 | |
Derivative financial instruments | Note 29 | 0 | 3 |
Total short-term debt | 779 | 427 | |
Gross debt | 4,972 | 4,090 | |
| Minus: | |||
Cash and cash equivalents | Note 26 | (932) | (954) |
Collateral | (12) | (2) | |
Deferred divestment consideration receivable | (4) | 0 | |
| Derivative financial instruments: | |||
Non-current assets | Note 21 | - | - |
Current assets | Note 25 | 0 | 0 |
Net debt | 4,024 | 3,134 |
| Gross debt, excluding lease liabilities, derivative financial instruments, and bank overdrafts | |||||||
| Foreign | |||||||
| Balance at | Proceeds | exchange | Balance at | ||||
| January 1, | from new | Acquisitions/ | Unwinding | and other | December | ||
| 2025 | issuances Repayments | Divestments | of discount | movements | 31, 2025 | ||
Bonds | 3,324 | 1,000 | - | - | 3 | (5) | 4,322 |
Private placements | 122 | - | - | - | - | (14) | 108 |
Other gross debt | 373 | 925 | (1,098) | 47 | 0 | (1) | 246 |
Total | 3,819 | 1,925 | (1,098) | 47 | 3 | (20) | 4,676 |
| Foreign | |||||||
| Balance at | Proceeds | exchange | Balance at | ||||
| January 1, | from new | Acquisitions/ | Unwinding | and other | December | ||
| 2024 | issuances Repayments | Divestments | of discount | movements | 31, 2024 | ||
Bonds | 3,123 | 600 | (400) | - | 3 | (2) | 3,324 |
Private placements | 127 | - | - | 0 | - | (5) | 122 |
Other gross debt | 76 | 637 | (338) | (3) | 0 | 1 | 373 |
Total | 3,326 | 1,237 | (738) | (3) | 3 | (6) | 3,819 |
| Lease liabilities | |||
current and non-current | 2025 | 2024 | |
Position at January 1 | 242 | 272 | |
Additions from new leases | 44 | 23 | |
Acquired through business combinations | 4 | 4 | |
Divestment of operations | (6) | - | |
Contract modifications and reassessments of options | 10 | (4) | |
Repayment of lease liabilities (interest and principal portion) | (65) | (70) | |
Unwinding of discount of lease liabilities | Note 14 | 7 | 8 |
Foreign exchange differences | (19) | 9 | |
Position at December 31 | Note 19 | 217 | 242 |
| 2025 | |
2027 | 557 |
2028 | 543 |
2029 | 599 |
2030 | 997 |
Due after 2030 | 1,337 |
Long-term debt | 4,033 |
Short-term debt (2026) | 722 |
Total (excluding lease liabilities) | 4,755 |
2025 | 2024 | |
Revenues | (40) | (40) |
Adjusted operating profit | (14) | (14) |
Operating profit | (14) | (13) |
Adjusted net profit | (11) | (12) |
Profit for the year | (11) | (11) |
Shareholders’ equity at December 31 | (29) | (29) |
Adjusted free cash flow | (12) | (12) |
| Derivative financial instruments sensitivity | |||||
| Exchange rate | Interest rate | ||||
| in millions, unless | Type of | movement | movement | ||
otherwise stated | Hedged risk | Amount | instrument | € | € |
| Changes in ¥ floating | Cross - currency | ||||
| interest payments and ¥ | interest rate | ||||
| Cash flow hedge | exchange rates | ¥20,000 | swaps | (1) | 2 |
| Changes of the U.S. dollar | |||||
| net investments due to | |||||
| fluctuations of U.S. dollar | Forward | ||||
| Net investment hedge | exchange rates | $300 | contracts | 2 | 0 |
| Contractual cash flows 2025 | ||||||
| Contractual | More | |||||
| Carrying | undiscounted | Less than | than 5 | |||
| Non-derivative financial liabilities | value | cash flows | 1 year | 1-2 years | 2-5 years | years |
| (excl. lease liabilities) | ||||||
| Bonds: | ||||||
Bonds 2008-2028 | 36 | 42 | 2 | 2 | 38 | - |
Bonds 2017-2027 | 500 | 516 | 8 | 508 | - | - |
Bonds 2020-2030 | 498 | 519 | 4 | 4 | 511 | - |
Bonds 2021-2028 | 499 | 503 | 1 | 1 | 501 | - |
Bonds 2022-2026 | 500 | 515 | 515 | - | - | - |
Bonds 2023-2031 | 696 | 857 | 26 | 26 | 79 | 726 |
Bonds 2024-2029 | 599 | 679 | 20 | 20 | 639 | - |
Bonds 2025-2032 | 495 | 619 | 17 | 17 | 51 | 534 |
Bonds 2025-2030 | 499 | 575 | 15 | 15 | 545 | - |
| Private placements: | ||||||
Private placements 2008-2038 | 108 | 155 | 4 | 4 | 11 | 136 |
Long- and short-term deferred and contingent acquisition payables | 50 | 50 | 1 | 49 | 0 | - |
Other debt | 16 | 16 | - | 8 | 8 | - |
Borrowings and bank overdrafts | 221 | 221 | 221 | - | - | - |
Trade payables | 131 | 131 | 131 | - | - | - |
Total | 4,848 | 5,398 | 965 | 654 | 2,383 | 1,396 |
| Derivative financial instruments | ||||||
(Receipts) | (256) | (256) | ||||
Payments | 253 | 253 | ||||
Foreign exchange derivatives | 0 | (3) | (3) | 0 | 0 | 0 |
(Receipts) (155) | (4) | (4) | (11) | (136) | ||
Payments | 222 | 8 | 8 | 23 | 183 | |
Cross-currency interest rate swaps | 38 | 67 | 4 | 4 | 12 | 47 |
| Total derivative financial liabilities/ | ||||||
(assets) | 38 | 64 | 1 | 4 | 12 | 47 |
| Contractual cash flows 2024 | ||||||
| Contractual | More | |||||
| Carrying | undiscounted | Less than | than 5 | |||
| Non-derivative financial liabilities | value | cash flows | 1 year | 1-2 years | 2-5 years | years |
| (excl. lease liabilities) | ||||||
| Bonds: | ||||||
Bonds 2008-2028 | 36 | 45 | 2 | 2 | 41 | - |
Bonds 2017-2027 | 499 | 524 | 8 | 8 | 508 | - |
Bonds 2020-2030 | 497 | 523 | 4 | 4 | 11 | 504 |
Bonds 2021-2028 | 499 | 505 | 1 | 1 | 503 | - |
Bonds 2022-2026 | 499 | 530 | 15 | 515 | - | - |
Bonds 2023-2031 | 695 | 884 | 26 | 26 | 79 | 753 |
Bonds 2024-2029 | 599 | 699 | 20 | 20 | 659 | - |
| Private placements: | ||||||
Private placements 2008-2038 | 122 | 177 | 4 | 4 | 12 | 157 |
Long- and short-term deferred and contingent acquisition payables | 2 | 2 | 2 | 0 | - | - |
Other debt | 21 | 21 | - | 11 | 10 | - |
Borrowings and bank overdrafts | 359 | 359 | 359 | - | - | - |
Trade payables | 159 | 159 | 159 | - | - | - |
Total | 3,987 | 4,428 | 600 | 591 | 1,823 | 1,414 |
| Derivative financial instruments | ||||||
(Receipts) | (286) | (286) | ||||
Payments | 281 | 281 | ||||
Foreign exchange derivatives | 3 | (5) | (5) | 0 | 0 | 0 |
(Receipts) | (177) | (4) | (4) | (12) | (157) | |
Payments | 230 | 8 | 8 | 23 | 191 | |
Cross-currency interest rate swaps | 17 | 53 | 4 | 4 | 11 | 34 |
| Total derivative financial liabilities/ | ||||||
(assets) | 20 | 48 | (1) | 4 | 11 | 34 |
2025 | 2024 | ||||||
| Non-derivative financial instruments: | Carrying value | Fair value | Level 1 | Level 2 | Level 3 Carrying value | Fair value | |
Financial assets at fair value through profit or loss | 0 | 0 | 0 | 0 | 0 | ||
Unbilled revenues* | 80 | 80 | 80 | 80 | |||
Trade receivables* | 1,075 | 1,075 | 1,129 | 1,129 | |||
VAT, sales tax, and other taxation* | 19 | 19 | 22 | 22 | |||
Miscellaneous receivables* | 14 | 14 | 16 | 16 | |||
Interest receivable* | 1 | 1 | 1 | 1 | |||
Deferred divestment consideration receivable* | 4 | 4 | 0 | 0 | |||
Cash and cash equivalents* | 932 | 932 | 954 | 954 | |||
Total non-derivative financial assets | 2,125 | 2,125 | 0 | 2,202 | 2,202 | ||
Bonds 2008-2028 | 36 | 39 | 39 | 36 | 40 | ||
Bonds 2017-2027 | 500 | 495 | 495 | 499 | 487 | ||
Bonds 2020-2030 | 498 | 451 | 451 | 497 | 444 | ||
Bonds 2021-2028 | 499 | 474 | 474 | 499 | 462 | ||
Bonds 2022-2026 | 500 | 501 | 501 | 499 | 501 | ||
Bonds 2023-2031 | 696 | 716 | 716 | 695 | 723 | ||
Bonds 2024-2029 | 599 | 607 | 607 | 599 | 609 | ||
Bonds 2025-2032 | 495 | 496 | 496 | - | - | ||
Bonds 2025-2030 | 499 | 497 | 497 | - | - | ||
Private placements 2008-2038 | 108 | 114 | 114 | 122 | 140 | ||
Long- and short-term deferred and contingent acquisition payables | 50 | 50 | 50 | 2 | 2 | ||
Other debt* | 16 | 16 | 21 | 21 | |||
Borrowings and bank overdrafts* | 221 | 221 | 359 | 359 | |||
Trade payables* | 131 | 131 | 159 | 159 | |||
Interest payable* | 68 | 68 | 51 | 51 | |||
Total non-derivative financial liabilities | 4,916 | 4,876 | 4,276 | 114 | 50 | 4,038 | 3,998 |
| Derivative financial instruments: | |||||||
| Non-current assets | - | - | - | - | |||
Current assets | 0 | 0 | - | - | |||
Total derivative financial assets | 0 | 0 | 0 | 0 | |||
Non-current liabilities | 38 | 38 | 38 | 17 | 17 | ||
Current liabilities | 0 | 0 | 0 | 3 | 3 | ||
Total derivative financial liabilities | 38 | 38 | 38 | 20 | 20 |
| The Level 3 fair value movements in non-derivative financial liabilities | |||
2025 | 2024 | ||
Balance at January 1 | 2 | 5 | |
Acquired through business combinations | Note 8 | 49 | 0 |
Settlements | Note 8 | (2) | (3) |
Fair value changes of contingent considerations | Note 11 | 0 | 0 |
Unwinding of discount of contingent consideration | Note 14 | 0 | - |
Foreign exchange differences | 1 | 0 | |
Balance at December 31 | 50 | 2 |
| Fair value of the deferred and contingent acquisition payables balance | |||||
| Fair value | Maximum | Fair value | |||
| December 31, | Of which: short | Of which: long | exposure | December 31, | |
| 2025 | term | term | (undiscounted) | 2024 | |
Total | 50 | 1 | 49 | 63 | 2 |
2025 | 2024 | |
Retirement plans | 9 | 11 |
Other post-employment benefit plans | 44 | 47 |
Other long-term employment benefit plans | 9 | 9 |
Total | 62 | 67 |
in % | 2025 | 2024 |
| Retirement plans | ||
Discount rate to discount the obligations at year-end | 4.3 | 3.6 |
Discount rate for pension expense | 3.6 | 3.3 |
Expected rate of pension increases (in payment) at year-end | 3.7 | 3.1 |
Expected rate of pension increases (in deferral) at year-end | 3.7 | 3.1 |
Expected rate of inflation increase for pension expense | 2.0 | 2.2 |
| Other post-employment benefit plans | ||
Discount rate to discount the obligations at year-end | 4.6 | 4.8 |
Discount rate for pension expense | 4.8 | 4.3 |
Medical cost trend rate | 3.0 | 3.0 |
in years | The Netherlands | United Kingdom |
Life expectancy at age of 65 now – Male | 22.1 | 21.6 |
Life expectancy at age of 65 now – Female | 24.5 | 23.7 |
Life expectancy aged 65 in 20 years – Male | 24.0 | 22.7 |
Life expectancy aged 65 in 20 years – Female | 26.4 | 25.2 |
| Sensitivity retirement plans | |||
| Gross service cost | |||
(excluding interest) | Defined benefit obligations | ||
2025 | Baseline | 16 | 1,271 |
| Decrease of | Increase of | Decrease of | Increase of | |
| Change compared to baseline | assumption | assumption | assumption | assumption |
Discount rate (change by 1%) | 5 | (3) | 218 | (171) |
Pension increase rate (change by 0.5%) | (1) | 2 | (87) | 98 |
Inflation increase rate (change by 0.5%) | (2) | 3 | (157) | 192 |
| Mortality table (change by 1 year) | - | 0 | (2) | 53 |
| Sensitivity of other post-employment plans | |||
| Gross service costs | |||
(excluding interest) | Defined benefit obligations | ||
2025 | Baseline | 1 | 44 |
| Change compared to baseline | |||
Discount rate (change by -1%) | 0 | (3) | |
Discount rate (change by +1%) | 0 | 3 |
| Plan liabilities and plan assets | ||||
| Defined benefit | Other post-employment | |||
| retirement plans | plans | |||
| Plan liabilities | 2025 | 2024 | 2025 | 2024 |
Fair value at January 1 | 1,369 | 1,352 | 47 | 45 |
Employer service cost | 13 | 15 | 1 | 1 |
Interest expense on defined benefit obligations | 49 | 44 | 2 | 2 |
Administration costs and taxes | 2 | 2 | - | - |
Benefits paid by fund | (52) | (55) | - | - |
| Benefits paid by employer | - | - | (3) | (3) |
Remeasurement (gains)/losses | (50) | 25 | - | - |
| Acquired through business combinations | - | 1 | 0 | - |
Contributions by plan participants | 4 | 4 | - | - |
Settlements | (57) | - | - | - |
Plan amendments and curtailments | 1 | (27) | - | - |
Foreign exchange differences | (9) | 8 | (3) | 2 |
Fair value at December 31 | 1,270 | 1,369 | 44 | 47 |
| Plan assets | ||||
Fair value at January 1 | 1,358 | 1,337 | - | - |
Interest income on plan assets | 49 | 44 | - | - |
Return on plan assets greater than discount rate | (46) | 6 | - | - |
Benefits paid by fund | (52) | (55) | (3) | (3) |
| Acquired through business combinations | - | 1 | - | - |
Contributions by employer | 14 | 13 | 3 | 3 |
Contributions by plan participants | 4 | 4 | - | - |
Settlements | (57) | - | - | - |
Foreign exchange differences | (9) | 8 | - | - |
Fair value at December 31 | 1,261 | 1,358 | 0 | 0 |
| Funded status | ||||
Deficit/(surplus) at December 31 | 9 | 11 | 44 | 47 |
| Irrecoverable surplus | - | 0 | - | - |
Net liability at December 31 | 9 | 11 | 44 | 47 |
| Pension expenses | |||||
| Defined benefit | Other post-employment | ||||
| retirement plans | plans | ||||
2025 | 2024 | 2025 | 2024 | ||
Employer service cost | 13 | 15 | 1 | 1 | |
Past service costs – plan amendment loss/(gain) | 1 | (27) | - | - | |
| Interest expense on irrecoverable surplus | - | 0 | - | - | |
Interest expense on defined benefit obligations | 49 | 44 | 2 | 2 | |
Interest income on plan assets | (49) | (44) | - | - | |
Administration costs and taxes | 2 | 2 | 0 | - | |
Total pension expense | 16 | (10) | 3 | 3 | |
| Of which is included in: | |||||
Employee benefit expenses | Note 12 | 16 | (11) | 1 | 1 |
Other finance (income)/costs | Note 14 | 0 | 1 | 2 | 2 |
2025 | 2024 | |
Position at January 1 | (126) | (121) |
Recognized in other comprehensive income | 4 | (5) |
Cumulative amount at December 31 | (122) | (126) |
| Remeasurement gains/(losses) for the year | ||
2025 | 2024 | |
Remeasurement gains/(losses) due to experience adjustments | 2 | 16 |
| Remeasurement gains/(losses) due to changes in demographic assumptions | - | 3 |
Remeasurement gains/(losses) due to changes in financial assumptions | 48 | (44) |
Remeasurement gains/(losses) on defined benefit obligations | 50 | (25) |
Return on plan assets greater/(lower) than discount rate | (46) | 6 |
| Change in irrecoverable surplus, other than interest and foreign exchange | ||
differences | 0 | 14 |
Recognized remeasurement gains on defined benefit plans in other comprehensive income | 4 | (5) |
number of years | 2025 | 2024 |
| Retirement plans | ||
The Netherlands | 16.0 | 16.5 |
United Kingdom | 10.4 | 10.7 |
| United States | - | 8.7 |
| Other post-employment plans | ||
United States | 6.1 | 6.3 |
| Equity | 2025 | Quoted | Unquoted | 2024 | Quoted | Unquoted |
Equity | 356 | 356 | - | 392 | 392 | - |
Private equity | 1 | - | 1 | 1 | - | 1 |
| Bonds | ||||||
Government bonds | 420 | 420 | - | 396 | 396 | - |
Corporate bonds | 160 | 160 | - | 177 | 177 | - |
Other bonds | 0 | - | - | 0 | - | - |
Asset-backed securities | 93 | 93 | - | 111 | 111 | - |
Other Insurance contracts | 136 | 73 | 63 | 205 | 77 | 128 |
Real estate | 86 | 41 | 45 | 97 | 45 | 52 |
Derivatives and other securities | (57) | (57) | - | (27) | (27) | - |
Cash | 66 | 66 | - | 6 | 6 | - |
Total | 1,261 | 1,152 | 109 | 1,358 | 1,177 | 181 |
| Proportion of plan assets | ||
in % | 2025 | 2024 |
Equity | 28 | 29 |
Bonds | 53 | 50 |
Other | 19 | 21 |
Total | 100 | 100 |
2025 | 2024 | |
Provision for restructuring commitments | 24 | 16 |
Provision for acquisition integration | 1 | 1 |
Restructuring provisions | 25 | 17 |
Legal provisions | 9 | 11 |
Other provisions | 4 | 5 |
Total | 38 | 33 |
Of which short term | 33 | 28 |
| Movements in provisions | ||||||
| Restructuring | Legal | Other | ||||
| provisions | provisions | provisions | 2025 | 2024 | ||
Long-term provisions at January 1 | 1 | 2 | 2 | 5 | 5 | |
Add: short-term provisions | 16 | 9 | 3 | 28 | 21 | |
Total provisions at January 1 | 17 | 11 | 5 | 33 | 26 | |
| Movements | ||||||
Additions for restructuring of stranded costs | Note 8 | 3 | - | - | 3 | 1 |
Additions for acquisition integration | Note 11 | 1 | - | - | 1 | - |
Other additions | 16 | 3 | 2 | 21 | 18 | |
Total additions | 20 | 3 | 2 | 25 | 19 | |
Appropriation of provisions | (8) | - | - | (8) | (9) | |
Release of provisions | (3) | (4) | (2) | (9) | (5) | |
Divestment of operations | 0 | - | (1) | (1) | 0 | |
Exchange differences | (1) | (1) | - | (2) | 2 | |
Total movements | 8 | (2) | (1) | 5 | 7 | |
Total provisions at December 31 | 25 | 9 | 4 | 38 | 33 | |
Less: short-term provisions | (23) | (8) | (2) | (33) | (28) | |
Long-term provisions at December 31 | 2 | 1 | 2 | 5 | 5 |
| Number of shares | ||||||
| Number of ordinary | Minus: number of | Total number of ordinary | ||||
| in thousands of shares, unless | shares | treasury shares | shares outstanding | |||
otherwise stated | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
At January 1 | 238,516 | 248,516 | (4,150) | (8,005) | 234,366 | 240,511 |
Cancelation of shares | (6,000) | (10,000) | 6,000 | 10,000 | 0 | 0 |
| Repurchased shares | - | - | (8,563) | (6,701) | (8,563) | (6,701) |
| Long-term incentive plan | - | - | 371 | 556 | 371 | 556 |
At December 31 | 232,516 | 238,516 | (6,342) | (4,150) | 226,174 | 234,366 |
Issued share capital at €0.12 (€’000) | 27,902 | 28,622 | ||||
Proposed dividend per share (€) | 2.52 | 2.33 | ||||
| Proposed dividend distribution | ||||||
(€’000) | 573,604 | 547,818 |
| Dividend distributions over financial year | |||
2025 | 2024 | 2023 | |
Originally proposed dividend over financial year | 574 | 548 | 503 |
| Actual payments: | |||
Interim dividend (paid in the financial year) | 214 | 196 | 176 |
Final dividend (paid in the subsequent financial year) | 349 | 324 | |
Total dividend distribution | 545 | 500 |
2025 | 2024 | |
Long-term incentive plan | 22 | 27 |
Restricted Stock Units | 4 | 4 |
Total equity-settled share-based payments | 26 | 31 |
| Fair value of Adjusted EPS | ||
| and ROIC shares at grant | Fair value TSR shares | |
| date | at grant date | |
LTIP 2025-27 | 152.46 | 107.99 |
LTIP 2024-26 | 121.35 | 86.87 |
LTIP 2023-25 | 91.37 | 68.72 |
LTIP 2022-24 | 97.82 | 71.71 |
| LTIP 2022-24: number of shares vested and the cash equivalent thereof | ||||||
| Increase in | Increase in | Increase in | ||||
| conditional | conditional | conditional | Payout/ | |||
| Outstanding | number of | number of | number of | vested shares | Cash value | |
| number of shares, | at December | EPS shares | ROIC shares | TSR shares | February 27, | vested |
| unless otherwise stated | 31, 2024 | (45%) | (50%) | (25%) | 2025 | shares* |
Executive Board | 57,285 | 6,543 | 4,846 | 8,263 | 76,937 | 11,521 |
Senior management | 199,459 | 26,926 | 20,018 | 24,959 | 271,362 | 40,637 |
Total | 256,744 | 33,469 | 24,864 | 33,222 | 348,299 | 52,158 |
| LTIP 2023-25 | ||||
| Adjusted | ||||
number of shares | Total | EPS-condition | ROIC-condition | TSR-condition |
Conditionally awarded grant 2023 | 338,699 | 98,605 | 65,708 | 174,386 |
Forfeited in previous years | (34,483) | (10,331) | (6,885) | (17,267) |
Shares outstanding at January 1, 2025 | 304,216 | 88,274 | 58,823 | 157,119 |
Forfeited during the year | (24,649) | (7,376) | (4,912) | (12,361) |
Effect of 98% vesting – EPS-performance | (1,619) | (1,619) | - | - |
Effect of 77% vesting – ROIC-performance | (12,405) | - | (12,405) | - |
Effect of 0% vesting – TSR-ranking | (144,758) | - | - | (144,758) |
Vested at December 31, 2025 | 120,785 | 79,279 | 41,506 | 0 |
| LTIP 2024-26 | ||||
| Adjusted | ||||
base number of shares at 100% payout | Total | EPS-condition | ROIC-condition | TSR-condition |
Conditionally awarded grant 2024 | 263,249 | 76,193 | 50,764 | 136,292 |
Forfeited in previous years | (7,362) | (2,209) | (1,472) | (3,681) |
Shares outstanding at January 1, 2025 | 255,887 | 73,984 | 49,292 | 132,611 |
Forfeited during the year | (23,169) | (6,927) | (4,613) | (11,629) |
Shares outstanding at December 31, 2025 | 232,718 | 67,057 | 44,679 | 120,982 |
| LTIP 2025-27 | ||||
| Adjusted | ||||
base number of shares at 100% payout | Total | EPS-condition | ROIC-condition | TSR-condition |
Conditionally awarded grant 2025 | 254,276 | 72,903 | 48,572 | 132,801 |
Forfeited during the year | (11,317) | (3,395) | (2,263) | (5,659) |
Shares outstanding at December 31, 2025 | 242,959 | 69,508 | 46,309 | 127,142 |
| Overview of outstanding performance shares: LTIP 2024-26 and LTIP 2025-27 | |||
base number of shares at 100% payout | LTIP 2024-26 | LTIP 2025-27 | Total |
Conditionally awarded grant 2024 | 263,249 | - | 263,249 |
Forfeited in previous years | (7,362) | - | (7,362) |
Shares outstanding at January 1, 2025 | 255,887 | - | 255,887 |
| Conditionally awarded grant 2025 | - | 254,276 | 254,276 |
Forfeited during the year | (23,169) | (11,317) | (34,486) |
Shares outstanding at December 31, 2025 | 232,718 | 242,959 | 475,677 |
| Fair value | |||
| RSU shares | |||
| at grant | |||
| date | |||
| November 1 | |||
RSU shares 2023 – one-year vesting period | 107.56 | 114.26 | 118.96 |
RSU shares 2023 – two-years vesting period | 105.46 | 111.98 | 116.55 |
RSU shares 2023 – three-years vesting period | 103.11 | 109.43 | 113.86 |
RSU shares 2024 – one-year vesting period | 143.68 | 152.45 | 152.22 |
RSU shares 2024 – two-years vesting period | 141.25 | 149.83 | 149.43 |
RSU shares 2024 – three-years vesting period | 138.72 | 146.88 | 146.30 |
RSU shares 2025 – one-year vesting period | 145.18 | ||
RSU shares 2025 – two-years vesting period | 142.53 | ||
RSU shares 2025 – three-years vesting period | 139.63 |
| Overview of outstanding performance shares | ||||
| Grant date | ||||
| Conditionally awarded number of RSU | Total number | Grant date | Grant date | November 1, |
| shares, grant 2023 | of RSU shares | March 1, 2023 | July 1, 2023 | 2023 |
One-year vesting period | 12,873 | 11,951 | 333 | 589 |
Two-years vesting period | 12,845 | 11,924 | 332 | 589 |
Three-years vesting period | 12,752 | 11,832 | 332 | 588 |
Total shares conditionally awarded | 38,470 | 35,707 | 997 | 1,766 |
Forfeitures during 2023 and 2024 | (1,971) | (1,971) | - | - |
Vesting in 2024 | (12,516) | (11,594) | (333) | (589) |
Shares outstanding at December 31, 2024 | 23,983 | 22,142 | 664 | 1,177 |
Forfeitures during the year 2025 | (2,439) | (1,917) | - | (522) |
Vesting in 2025 | (11,455) | (10,599) | (332) | (524) |
Shares outstanding at December 31, 2025 | 10,089 | 9,626 | 332 | 131 |
| Grant date | ||||
| Conditionally awarded number of RSU | Total number | Grant date | Grant date | November 1, |
| shares, grant 2024 | of RSU shares | March 1, 2024 | July 1, 2024 | 2024 |
One-year vesting period | 11,678 | 10,701 | 323 | 654 |
Two-years vesting period | 11,549 | 10,575 | 323 | 651 |
Three-years vesting period | 11,451 | 10,477 | 323 | 651 |
Total shares conditionally awarded | 34,678 | 31,753 | 969 | 1,956 |
Forfeitures during the year 2024 | (1,137) | (1,137) | - | - |
Vesting in 2024 | 0 | - | - | - |
Shares outstanding at December 31, 2024 | 33,541 | 30,616 | 969 | 1,956 |
Forfeitures during the year 2025 | (1,818) | (1,818) | - | - |
Vesting in 2025 | (11,230) | (10,253) | (323) | (654) |
Shares outstanding at December 31, 2025 | 20,493 | 18,545 | 646 | 1,302 |
| Grant date | ||||||
| Conditionally awarded number of RSU shares, | Total number | Grant date | Grant date | November 1, | ||
| grant 2025 | of RSU shares | March 1, 2025 | July 1, 2025 | 2025 | ||
One-year vesting period | 10,363 | 10,363 | ||||
Two-years vesting period | 9,729 | 9,729 | ||||
Three-years vesting period | 9,729 | 9,729 | ||||
Total shares conditionally awarded | 29,82 | 1 | 29,821 | - | - | |
Forfeitures during 2025 | (2,103) | (2,103) | - | - | ||
Shares outstanding at December 31, 2025 | 27,718 | 27,718 | 0 | 0 | ||
| Total conditionally awarded number of RSU | Total number | RSU grant in | RSU grant in | RSU grant in |
| shares | of RSU shares | 2023 | 2024 | 2025 |
Shares outstanding at January 1, 2024 | 37,542 | 37,542 | - | - |
Conditionally awarded in 2024 | 34,678 | - | 34,678 | - |
Vesting in 2024 | (12,516) | (12,516) | - | - |
Forfeitures during the year 2024 | (2,180) | (1,043) | (1,137) | - |
Shares outstanding at January 1, 2025 | 57,524 | 23,983 | 33,541 | 0 |
Conditionally awarded in 2025 | 29,821 | - | - | 29,821 |
Forfeitures during the year 2025 | (6,360) | (2,439) | (1,818) | (2,103) |
Vesting in 2025 | (22,685) | (11,455) | (11,230) | - |
Shares outstanding at December 31, 2025 | 58,300 | 10,089 | 20,493 | 27,718 |
| Audit fees 2025 | |||
| KPMG | Other KPMG | ||
| Accountants | member firms | ||
| N.V. | and affiliates | Total KPMG | |
Statutory audit of annual accounts | 1.5 | 2.2 | 3.8 |
| Other statutory audits | - | 0.6 | 0.6 |
CSRD limited assurance | 0.3 | - | 0.3 |
Other assurance services | 0.0 | - | 0.0 |
| Tax advisory services | - | - | 0.0 |
| Other non-audit services | - | 0.0 | 0.0 |
Total | 1.8 | 2.9 | 4.7 |
| Audit fees 2024 | |||
| Deloitte | Other Deloitte | ||
| Accountants | member firms | ||
| B.V. | and affiliates | Total Deloitte | |
Statutory audit of annual accounts | 1.2 | 2.2 | 3.4 |
CSRD limited assurance | 0.3 | - | 0.3 |
Other assurance services | 0.1 | 0.3 | 0.4 |
| Tax advisory services | - | 0.0 | 0.0 |
Other non-audit services | 0.0 | 0.1 | 0.1 |
Total | 1.6 | 2.6 | 4.2 |
2025 | 2024 | ||
| Parental performance guarantees to third parties | - | 5 | |
Guarantee to the trustees of the U.K. retirement plan | Note 30 | 6 | 22 |
Real estate and other guarantees | 10 | 10 | |
Drawn bank credit facilities | 1 | 1 | |
Total | 17 | 38 |
in thousands of euros | 2025 | 2024 | ||
| Fixed compensation: | ||||
Salary | 3,017 | 2,387 | ||
Social security | 248 | 234 | ||
Defined contribution plan | 187 | 185 | ||
Other benefits* | 458 | 458 | ||
Total fixed compensation | 3,910 | 3,264 | ||
| Variable compensation: | ||||
STIP | 3,932 | 2,998 | ||
LTIP** | 5,956 | 6,260 | ||
Total variable compensation | 9,888 | 9,258 | ||
Sub-total fixed and variable compensation | 13,798 | 12,522 | ||
Tax-related costs*** | 1,191 | 199 | ||
Total remuneration Executive Board | 14,989 | 12,721 |
2025 | 2024 | |
Ms. N. McKinstry | 460,412 | 427,202 |
Ms. S.H. Caywood | 18,775 | 7,054 |
Mr. K.B. Entricken | 56,734 | 60,750 |
Total shares owned | 535,921 | 495,006 |
| Shares owned by Supervisory Board members | ||
2025 | 2024 | |
Mrs. A.E. Ziegler | 3,073 | 1,894 |
Mr. D.W. Sides | 1,875 | - |
Mr. J.P. de Kreij | 3,000 | - |
Total shares owned | 7,948 | 1,894 |